Lv1
30 积分 2024-06-14 加入
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
6小时前
已完结
Lung cancer incidence rates in young women and men by state in the United States
15天前
已完结
Current status of immune checkpoint inhibition in early-stage NSCLC
1个月前
已完结
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
2个月前
已完结
Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
2个月前
已完结
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy
2个月前
已完结
Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer
2个月前
已完结
Efficacy and Safety of Immune Checkpoint Inhibition Combined with Concurrent Chemoradiotherapy in Patients with Stage III Unresectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
2个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2个月前
已完结
FDA guideline for validation of the LAL test as an end-product endotoxin test for human and biological drugs
2个月前
已关闭
皖公网安备34019202002308
